识别肺部加重期表型能否指导囊性纤维化的新治疗方法？ - Suppr

Can Identifying Pulmonary Exacerbation Phenotypes Guide New Treatment Approaches for Cystic Fibrosis?

作者信息

Caverly Lindsay J

机构信息

Division of Pediatric Pulmonology, University of Michigan Medical School, Ann Arbor, Michigan.

出版信息

Ann Am Thorac Soc. 2022 Nov;19(11):1799-1801. doi: 10.1513/AnnalsATS.202208-703ED.

DOI:10.1513/AnnalsATS.202208-703ED

PMID:36318079

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9667808/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/b2b1/9667808/fe62df3acd24/AnnalsATS.202208-703EDUf1.jpg

相似文献

Can Identifying Pulmonary Exacerbation Phenotypes Guide New Treatment Approaches for Cystic Fibrosis?

Ann Am Thorac Soc. 2022 Nov;19(11):1799-1801. doi: 10.1513/AnnalsATS.202208-703ED.

Rationale and design of a randomized trial of home electronic symptom and lung function monitoring to detect cystic fibrosis pulmonary exacerbations: the early intervention in cystic fibrosis exacerbation (eICE) trial.

Contemp Clin Trials. 2013 Nov;36(2):460-9. doi: 10.1016/j.cct.2013.09.004. Epub 2013 Sep 19.

Positive expiratory pressure physiotherapy for airway clearance in people with cystic fibrosis.

Cochrane Database Syst Rev. 2015 Jun 17(6):CD003147. doi: 10.1002/14651858.CD003147.pub4.

[Lung physiotherapy in cystic fibrosis].

Tidsskr Nor Laegeforen. 1991 Feb 28;111(6):720-2.

Quality of life and healthcare utilisation in cystic fibrosis: a multicentre study.

Eur Respir J. 2013 Mar;41(3):571-7. doi: 10.1183/09031936.00224911. Epub 2012 Jul 26.

Pulmonary artery enlargement and cystic fibrosis pulmonary exacerbations: a cohort study.

Lancet Respir Med. 2016 Aug;4(8):636-645. doi: 10.1016/S2213-2600(16)30105-9. Epub 2016 Jun 10.

Design and powering of cystic fibrosis clinical trials using pulmonary exacerbation as an efficacy endpoint.

J Cyst Fibros. 2011 Dec;10(6):453-9. doi: 10.1016/j.jcf.2011.07.003. Epub 2011 Jul 30.

Effect of pulmonary exacerbations on long-term lung function decline in cystic fibrosis.

Eur Respir J. 2012 Jul;40(1):61-6. doi: 10.1183/09031936.00159111. Epub 2011 Dec 1.

Cystic Fibrosis Frequently Asked Questions. Question 3: How do you define a pulmonary exacerbation in Cystic Fibrosis?

Paediatr Respir Rev. 2015 Sep;16(4):249-50. doi: 10.1016/j.prrv.2015.01.002.

Early Lung Function Decline in Cystic Fibrosis. Can Registry Data Explain Divergent Phenotypes?

Am J Respir Crit Care Med. 2017 Aug 15;196(4):407-409. doi: 10.1164/rccm.201704-0813ED.

引用本文的文献

Diminished airway host innate response in people with cystic fibrosis who experience frequent pulmonary exacerbations.

Eur Respir J. 2024 Feb 22;63(2). doi: 10.1183/13993003.01228-2023. Print 2024 Feb.

本文引用的文献

Antibiotics and outcomes of CF pulmonary exacerbations in children infected with MRSA and Pseudomonas aeruginosa.

J Cyst Fibros. 2023 Mar;22(2):313-319. doi: 10.1016/j.jcf.2022.08.001. Epub 2022 Aug 7.

Acute Pulmonary Exacerbation Phenotypes in Patients with Cystic Fibrosis.

Ann Am Thorac Soc. 2022 Nov;19(11):1818-1826. doi: 10.1513/AnnalsATS.202111-1266OC.

C-reactive protein (CRP) as a biomarker of pulmonary exacerbation presentation and treatment response.

J Cyst Fibros. 2022 Jul;21(4):588-593. doi: 10.1016/j.jcf.2021.12.003. Epub 2021 Dec 18.

A Randomized Clinical Trial of Antimicrobial Duration for Cystic Fibrosis Pulmonary Exacerbation Treatment.

Am J Respir Crit Care Med. 2021 Dec 1;204(11):1295-1305. doi: 10.1164/rccm.202102-0461OC.

Association Between Number of Intravenous Antipseudomonal Antibiotics and Clinical Outcomes of Pediatric Cystic Fibrosis Pulmonary Exacerbations.

Clin Infect Dis. 2021 Nov 2;73(9):1589-1596. doi: 10.1093/cid/ciab525.

Antimicrobial resistance: Concerns of healthcare providers and people with CF.

J Cyst Fibros. 2021 May;20(3):407-412. doi: 10.1016/j.jcf.2020.05.009. Epub 2020 Jun 17.

The use of antimicrobial susceptibility testing in pediatric cystic fibrosis pulmonary exacerbations.

J Cyst Fibros. 2019 Nov;18(6):851-856. doi: 10.1016/j.jcf.2019.05.012. Epub 2019 May 28.

Standardized Treatment of Pulmonary Exacerbations (STOP) study: Observations at the initiation of intravenous antibiotics for cystic fibrosis pulmonary exacerbations.

J Cyst Fibros. 2017 Sep;16(5):592-599. doi: 10.1016/j.jcf.2017.04.005. Epub 2017 Apr 29.

Standardized Treatment of Pulmonary Exacerbations (STOP) study: Physician treatment practices and outcomes for individuals with cystic fibrosis with pulmonary Exacerbations.

J Cyst Fibros. 2017 Sep;16(5):600-606. doi: 10.1016/j.jcf.2017.04.003. Epub 2017 Apr 29.

The cumulative effects of intravenous antibiotic treatments on hearing in patients with cystic fibrosis.

J Cyst Fibros. 2017 May;16(3):401-409. doi: 10.1016/j.jcf.2017.01.006. Epub 2017 Feb 24.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验

Can Identifying Pulmonary Exacerbation Phenotypes Guide New Treatment Approaches for Cystic Fibrosis?

作者信息

机构信息

出版信息

相似文献

引用本文的文献

本文引用的文献

文献AI研究员

用中文搜PubMed

文档翻译

Suppr 超能文献

相似文献

引用本文的文献

本文引用的文献